Annual ROE
-84.27%
+355.07%+80.82%
31 December 2023
Summary:
Aprea Therapeutics annual return on equity is currently -84.27%, with the most recent change of +355.07% (+80.82%) on 31 December 2023. During the last 3 years, it has fallen by -9.28% (-12.37%). APRE annual ROE is now -115.35% below its all-time high of 548.87%, reached on 01 June 2006.APRE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-57.86%
-1.48%-2.63%
30 September 2024
Summary:
Aprea Therapeutics quarterly return on equity is currently -57.86%, with the most recent change of -1.48% (-2.63%) on 30 September 2024. Over the past year, it has increased by +7.72% (+11.77%). APRE quarterly ROE is now -164.62% below its all-time high of 89.54%, reached on 30 September 2019.APRE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APRE ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +11.8% |
| 3 y3 years | -12.4% | +9.2% |
| 5 y5 years | -273.2% | +24.5% |
APRE ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -21.9% | +80.8% | -4.8% | +94.3% |
| 5 y | 5 years | -379.1% | +80.8% | -164.6% | +94.3% |
| alltime | all time | -115.3% | +80.8% | -164.6% | +94.3% |
Aprea Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -57.86%(+2.6%) |
| June 2024 | - | -56.38%(-0.7%) |
| Mar 2024 | - | -56.78%(-13.4%) |
| Dec 2023 | -84.27%(-80.8%) | -65.58%(+18.3%) |
| Sept 2023 | - | -55.45%(+0.4%) |
| June 2023 | - | -55.22%(-94.6%) |
| Mar 2023 | - | -1015.57%(+35.4%) |
| Dec 2022 | -439.34%(+485.9%) | -750.08%(+33.4%) |
| Sept 2022 | - | -562.17%(+26.1%) |
| June 2022 | - | -445.77%(+553.2%) |
| Mar 2022 | - | -68.24%(+7.1%) |
| Dec 2021 | -74.99% | -63.73%(-7.1%) |
| Sept 2021 | - | -68.63%(+6.8%) |
| June 2021 | - | -64.25%(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -64.04%(+13.7%) |
| Dec 2020 | -69.10%(+206.0%) | -56.31%(+17.4%) |
| Sept 2020 | - | -47.95%(-29.0%) |
| June 2020 | - | -67.57%(+10.9%) |
| Mar 2020 | - | -60.92%(-20.6%) |
| Dec 2019 | -22.58%(-174.8%) | -76.68%(-185.6%) |
| Sept 2019 | - | 89.54%(-113.3%) |
| June 2019 | - | -675.67%(-3176.8%) |
| Mar 2019 | - | 21.96%(+44.5%) |
| Dec 2018 | 30.19%(-28.9%) | 15.20% |
| Dec 2017 | 42.47%(-74.5%) | - |
| June 2008 | 166.74%(-68.6%) | - |
| June 2007 | 530.77%(-3.3%) | - |
| June 2006 | 548.87%(+132.2%) | - |
| Dec 2004 | 236.36% | - |
FAQ
- What is Aprea Therapeutics annual return on equity?
- What is the all time high annual ROE for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly ROE year-on-year change?
What is Aprea Therapeutics annual return on equity?
The current annual ROE of APRE is -84.27%
What is the all time high annual ROE for Aprea Therapeutics?
Aprea Therapeutics all-time high annual return on equity is 548.87%
What is Aprea Therapeutics quarterly return on equity?
The current quarterly ROE of APRE is -57.86%
What is the all time high quarterly ROE for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly return on equity is 89.54%
What is Aprea Therapeutics quarterly ROE year-on-year change?
Over the past year, APRE quarterly return on equity has changed by +7.72% (+11.77%)